Clinical Trial Details

NCT ID: NCT01250912
Date Last Changed: November 30, 2010


Research Study Summary

A clinical trial seeking patients for a research study for the treatment of Ventricular Tachycardia or Arrhythmia

Research Study Title

Three Dimension Neuron Imaging Using 123I-metaiodobenzylguanidine Single Photon Emission Computed Tomography to Guide Ventricular Tachycardia Ablations


Some patients are at risk for life-threatening fast heart rates. These can frequently be treated by using a catheter inside the heart to burn away the cells that create the fast heart rates. The purpose of this study is to image the nerves inside the heart of those patients. The investigators want to find out if abnormalities in the nervous system in the heart can help the physician to find the area that needs to be burnt away.

To Learn more

Recruitment Details

Both Male and Female
18 and up
Overall Status
Lead Sponsor
University of Maryland
33 Months
Facility Type


Both Male and Female ages 18 Years and up

Inclusion Criteria:

  • Patients with ventricular arrhythmias requiring VT Ablation

  • Patients must be 18 years of age or older

  • Patient must be able to sign consent form

  • Patient must be willing to come back for the 6 month visit for additional study procedures

Exclusion Criteria:

  • Patient under 18 years old

  • Inability to sign consent

  • Pregnant Women

Site Locations (1)

Country State City Zip Facility and Contact
United States Maryland Baltimore 21201 University of Maryland Medical Center, EP Lab, Rm. N3W77
Timm M Dickfeld, MD, Ph.D

Timm M Dickfeld, MD, Ph.D
Principal Investigator

Stephen R Shorofsky, MD, Ph.D

Anastasios P Saliaris, MD, Ph.D


Timm M Dickfeld, MD, Ph.D

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.